Switch to:
More From Other Websites
8:01 am Vertex Pharma receives CRL from the FDA over its sNDA for KALYDECO in people with cystic... Feb 07 2016
Here's Why Shares Of Vertex Pharmaceuticals Tumbled Feb 05 2016
Biotech stocks too risky? Feb 05 2016
Vertex Filing For Expanded Kalydeco Label Rejected By FDA Feb 05 2016
Vertex Receives Complete Response Letter from U.S. FDA for Use of KALYDECO® (ivacaftor) in People... Feb 05 2016
How Much Does Biogen Spend on Research and Development? Feb 03 2016
The Real Risks of Gilead’s Stock Feb 03 2016
Headline Risk Is Poison for Pharma and Biotech Feb 03 2016
Street Talk: VRTX, GPRO, TSLA, PGTI Feb 01 2016
Top Analyst Upgrades and Downgrades: Chipotle, Cisco, Micron, Seagate, Vertex, Disney, Xerox and... Feb 01 2016
Pre-Market Pulse on Biotechnology Stocks -- ZIOPHARM Oncology, BioMarin Pharma, PTC Therapeutics,... Feb 01 2016
Vertex Pharma upgraded by Jefferies Feb 01 2016
Biotech String: Assessing the January Damage, Gilead's Bottoming P/E, Sarepta Panel Date? Feb 01 2016
3 Key FDA Decisions Expected in February Jan 31 2016
Vertex Will Focus on Cystic Fibrosis Market in 2016 Jan 30 2016
Here Are the 5 Worst-Performing Stocks in the S&P 500 in 2016 Jan 29 2016
What's in Store for Nivalis (NVLS) this Earnings Season? Jan 29 2016
Vertex Pharmaceuticals, Inc. Earnings Analysis: Q4, 2015 By the Numbers Jan 29 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK